Herbal therapy to prevent infection after stem cell transplant
Treatments studied
Part of Blood & lymphatic, Digestive system, Infections clinical trials.
This trial tests whether a special herbal treatment applied to the skin can help prevent infections around the bottom that are caused by diarrhea after a stem cell transplant. It may be an option for people who are getting a transplant for the first time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be getting a stem cell transplant from a donor (allogeneic) for the first time.
- You must be between 14 and 70 years old.
- You must have a blood cancer or aplastic anemia.
- You must not have had an active intestinal infection in the last 2 weeks.
- You must not have inflammatory bowel disease or irritable bowel syndrome.
- You must be in good enough health to tolerate the transplant and the herbal treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a fecal transplant (transferring healthy donor bacteria into your gut) can help your immune system recover after a stem cell transplant. It may reduce the risk of infections while your immunity is still low.
This trial tests whether giving medication after a donor stem cell transplant can prevent the return of very high-risk myelodysplastic syndrome (MDS). It is for people who have a suitable donor and are healthy enough for the procedure.
This trial tests whether taking probiotics made from your own and your donor's bacteria can help prevent or reduce gut problems (like diarrhea) after a stem cell transplant. It may help your intestines recover and feel better.
This Phase 2 study tests an oral “fecal microbiotherapy” treatment given before and around an allogeneic (donor) stem-cell transplant to help prevent transplant-related complications. It may help by improving gut and immune function during the high-risk transplant period.
This trial tests whether adding back certain immune cells after a stem cell transplant can help prevent serious viral or fungal infections. It's for children and young adults up to age 25 who need a transplant for a blood cancer or other curable disease.
This trial tests a standard transplant preparation (chemotherapy and low-dose radiation) followed by a special drug (PTCy) to prevent graft-versus-host disease after a donor stem cell transplant for blood cancers. It may help improve transplant success and reduce complications.
Hear when a new Allogeneic Hematopoietic Stem Cell Transplantation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.